Search clinical trials for: Tegafur, Gimeracil and Oteracil Potassium

Total 1970 results

Chinese PLA General Hospital

Unknown

Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer

Unresectable Pancreatic Cancer

China
Yokohama City University

Unknown

S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

Head and Neck Cancer

Japan
Henan Cancer Hospital

Terminated

Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer

Advanced Cancer

China
Cancer Institute and Hospital, Chinese Academy...
Chinese PLA General Hospital; Peking University Cancer Hospital & Institute; Tianjin... and other collaborators

Unknown

Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer

Breast Cancer

China
Zhejiang Cancer Hospital

Recruiting

Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (Stars)

Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma

China
Peking University Cancer Hospital & Institute
Peking University People's Hospital; Peking Union Medical College Hospital; Cancer...

Recruiting

SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

Adjuvant Chemotherapy | Colorectal Cancer Stage III

China
Yu jiren

Active, not recruiting

Adjuvant Chemotherapy in Combination With Camrelizumab for Stage III Gastric Cancer (FOCUS-02)

Gastric Cancer Stage III

China
Kyoto University

Completed

S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer

Gastric Cancer

Japan
Peking Union Medical College Hospital

Not yet recruiting

CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer

Cervical Cancer | Chemotherapy
Kyoto University

Unknown

S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer

Gastric Cancer

Japan
Yonsei University

Unknown

S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery

Esophageal Cancer

Korea, Republic of
Fudan University

Unknown

Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric Carcinoma (NEWEAR)

Gastric Cancer

China
Fudan University

Terminated

A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer

China
Zhejiang Cancer Hospital

Recruiting

Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis

Nasopharyngeal Carcinoma

China
Tang Xushan

Unknown

Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer

Gastric Cancer

China
Yonsei University

Unknown

Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer

Gastric Cancer

Korea, Republic of
RenJi Hospital

Not yet recruiting

Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma

Gastric Cancer
Wuhan Union Hospital, China
LinkDoc Technology (Beijing) Co. Ltd.

Recruiting

Effect and Safety of Adjuvant Huaier Granule Versus Standard Chemotherapy Regimens in Gastric Cancer Patients

Gastric Cancer

China
Eastern Network of Cancer Immunological Therapy...

Terminated

Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma (eNCIT-Japan)

Gastric Cancer

Japan
Shanghai Cancer Hospital, China
Fudan University; Ruijin Hospital; Xinhua Hospital, Shanghai Jiao Tong University... and other collaborators

Recruiting

PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy (PREACT)

Adenocarcinoma | Chemoradiation | GastroEsophageal Cancer | Stomach Neoplasm | Locally Advanced Cancer

China
Sun Yat-sen University
Xiangya Hospital of Central South University; Wuhan University; Zhujiang Hospital and other collaborators

Recruiting

Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007) (EC-CRT-007)

Locally Advanced Esophageal Squamous Cell Carcinoma

China
Guangzhou University of Traditional Chinese Medicine

Not yet recruiting

Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer

Rectal Cancer | Colon Cancer | Metastasis Colorectal Cancer

China
Shanghai Ninth People's Hospital Affiliated to...

Unknown

A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers

Head and Neck Squamous Cell Carcinoma

China
Taiho Oncology, Inc.

Terminated

Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial (DIGEST)

Metastatic Diffuse Gastric Cancer Including Carcinoma of the Gastro-esophageal Junction

Belgium, Spain, United States, Italy, Estonia, Russian Federation, Bulgaria, Hungary, Croatia, Israel, Mexico, Poland, Portugal, Romania, South Africa, Ukraine, United Kingdom, Brazil, Germany, Argentina
Hebei Medical University

Completed

Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

Gastric Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer

Head and Neck Neoplasms

China
Fudan University

Recruiting

S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC）

Gastric Cancer

China
Yonsei University

Unknown

Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Head and Neck Cancer

Korea, Republic of
Shanghai Ninth People's Hospital Affiliated to...

Completed

A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Head and Neck Squamous Cell Carcinoma

China
Sunshine Lake Pharma Co., Ltd.

Recruiting

Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer

Esophageal Cancer

China
Fukushima Medical University Hospital

Unknown

S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer

Gastric Cancer

Japan
University of Edinburgh
NHS Lothian

Completed

Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine (TOFFEE)

Pancreatic Cancer | Gastrointestinal Cancer | Bile Duct Neoplasms | Cancer of Unknown Primary Site

United Kingdom
Sun Yat-sen University

Unknown

Trial of S-1 Plus Cisplatin in Gastric Cancer

Gastric Cancer

China
Fudan University

Recruiting

Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma

Gastric Cancer

China
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-4538 in Gastric Cancer

Gastric Cancer

Japan, Korea, Republic of, Taiwan
Fudan University

Unknown

A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites

Stomach Neoplasms | Gastric Cancer

China
Peking University

Recruiting

Apatinib With Oxaliplatin and S-1 Treatment for Advanced Hepatoid Adenocarcinoma Of The Stomach

Gastric Cancer

China
West China Hospital

Recruiting

Fruquintinib Plus S-1 and Raltitrexed (RSF) for mCRC

Fruquintinib | S-1 | Raltitrexed

China
Ono Pharmaceutical Co. Ltd

Recruiting

A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

Gastric Cancer

Korea, Republic of, Taiwan, Japan
Beijing Konruns Pharmaceutical Co., Ltd.

Recruiting

A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer

Esophageal Squamous Cell Carcinoma

China
AIPING ZHOU

Completed

Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer

Advanced Pancreatic Cancer

China
Fudan University

Recruiting

Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer (NeoRacing)

Adenocarcinoma | Stomach Neoplasms | Gastrectomy | Neoadjuvant Therapy | Immunotherapy | Adjuvant Therapy | Chemoradiotherapy | Esophagogastric Junction Disorder

China
Anhui Chest Hospital

Not yet recruiting

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung
Zhejiang University

Recruiting

Study of Comparing of With and Without Sequential Therapy of S-1

Chemotherapy Effect | Locally Advanced Gastric Adenocarcinoma

China
National Taiwan University Hospital
TTY Biopharm

Unknown

S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma
Sun Yat-sen University
Taiho Pharmaceutical Co., Ltd.

Completed

Study of S-1 Plus LV for Advanced Gastric Cancer

Gastric Cancer

China
The First Affiliated Hospital with Nanjing Medical...

Terminated

Endostar Combined With MPFC Adjuvant Treatment of Esophageal Cancer Clinical Trial

Esophageal

China
Lee's Pharmaceutical Limited

Not yet recruiting

A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer

Pancreatic Cancer

China
Osaka Medical College

Unknown

S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by Surgery

Colorectal Cancer

Japan
Quan Wang

Completed

The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer

Stomach Neoplasms

China

3

Subscribe